Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
Newborn screening (NBS) for mucopolysaccharidosis type I (MPS I, Hurler syndrome) is currently conducted in about two-fifths of the NBS programs in the United States and in a few other countries. Screening is performed by measurement of residual activity of the enzyme <i>alpha</i>-<sp...
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
MDPI AG
2020-10-01
|
| سلاسل: | International Journal of Neonatal Screening |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.mdpi.com/2409-515X/6/4/78 |